Clinicopathological and Molecular Evidence Indicating the Independence of Bronchioloalveolar Components from Other Subtypes of Human Peripheral Lung Adenocarcinoma

• Published in: Clinical cancer research 2001-06, Vol.7 (6), p.1730-1738
• Main Authors: KOGA, Takaomi, HASHIMOTO, Shuichi, SUGIO, Kenji, YOSHINO, Ichiro, MOJTAHEDZADEH, Sepideh, MATSUO, Yoshio, YONEMITSU, Yoshikazu, SUGIMACHI, Keizo, SUEISHI, Katsuo
• Format: Article
• Language: English
• Subjects: Adenocarcinoma - genetics; Adenocarcinoma - metabolism; Adenocarcinoma - pathology; Adenocarcinoma, Bronchiolo-Alveolar - genetics; Adenocarcinoma, Bronchiolo-Alveolar - metabolism; Adenocarcinoma, Bronchiolo-Alveolar - pathology; Aged; Biological and medical sciences; Disease-Free Survival; DNA Mutational Analysis; Exons; Female; Genes, p53 - genetics; Humans; Immunohistochemistry; Lung Neoplasms - genetics; Lung Neoplasms - metabolism; Lung Neoplasms - pathology; Male; Medical sciences; Middle Aged; Neoplasm Invasiveness; Pneumology; Prognosis; Time Factors; Tumors of the respiratory system and mediastinum
• ISSN: 1078-0432; 1557-3265

Although human lung adenocarcinoma has diverse histological subtypes, the correlation between histological subtypes and occurrence of the p53 gene mutation has been given less attention. We investigated 145 surgically resected lung adenocarcinomas to search for the incidence of p53 mutations and for record data on survival in each histological subtype, according to the new WHO criteria (1999). The frequency of p53 mutation in bronchioloalveolar carcinoma (BAC; 0% in 17 cases) and BAC with invasive growth component (BAC-invasive; 11% in 27 cases), which is conventionally categorized as the mixed subtype in WHO typing, were apparently significantly lower than in other types (non-BAC including acinar, papillary, solid, or mixed histology with these subtypes; 48% in 101 cases; P < 0.01). Multivariate analysis revealed that the histological subtype including BAC-invasive was a strong, independent, and significant prognostic factor ( P < 0.03), as were tumor size and pathological stage ( P < 0.001 and 0.002, respectively) for overall survival. However, the occurrence of p53 mutation itself was seen to be significant only in case of the univariate analysis. Therefore, histological subtyping may be a better prognostic indicator than is p53 mutation. These findings suggest that the WHO classification with the BAC and BAC-invasive from other histological subtypes may prove useful to predict the outcome for surgically treated patients with lung adenocarcinoma.